Background-Pretreatment with the volatile anesthetic sevoflurane protects cardiomyocytes against subsequent ischemic episodes caused by a protein kinase C (PKC)-␦ mediated preconditioning effect. Sevoflurane directly modulates cardiac Ca 2ϩ handling, and because Ca 2ϩ also serves as a mediator in other cardioprotective signaling pathways, possible involvement of the Na ϩ /Ca 2ϩ exchanger (NCX) in relation with PKC-␦ in sevoflurane-induced cardioprotection was investigated. Methods and Results-Isolated right ventricular rat trabeculae were subjected to simulated ischemia and reperfusion (SI/R), consisting of superfusion with hypoxic glucose-free buffer for 40 minutes after rigor development, followed by reperfusion with normoxic glucose containing buffer. Preconditioning with sevoflurane before SI/R improved isometric force development during contractile recovery at 60 minutes after the end of hypoxic superfusion (83Ϯ7% [sevo] versus 57Ϯ2% [SI/R];nϭ8; PϽ0.01). Inhibition of the reverse mode of the NCX by KB-R7943 (10 mol/L) or SEA0400(1 mol/L) during preconditioning attenuated the protective effect of sevoflurane. KB-R7943 and SEA0400 did not have intrinsic effects on the contractile recovery. Furthermore, inhibition of the NCX in trabeculae exposed to sevoflurane reduced sevoflurane-induced PKC-␦ translocation toward the sarcolemma, as demonstrated by digital imaging fluorescent microscopy. The degree of PKC-␦ phosphorylation at serine 643 as determined by western blot analysis was not affected by sevoflurane. Conclusions-Sevoflurane-induced cardioprotection depends on the NCX preceding PKC-␦ translocation presumably via increased NCX-mediated Ca 2ϩ influx. This may suggest that increased myocardial Ca 2ϩ load triggers the cardioprotective signaling cascade elicited by volatile anesthetic agents similar to other modes of preconditioning. Key Words: anesthesia Ⅲ calcium Ⅲ ion channels Ⅲ preconditioning Ⅲ signal transduction T he myocardium contains intrinsic protective mechanisms against ischemia/reperfusion (I/R) injury, which can be triggered by several stimuli, including volatile anesthetics like sevoflurane. The cardioprotective properties of sevoflurane depend on activating protein kinase C (PKC) and producing reactive oxygen species (ROS) similar to ischemic preconditioning and Ca 2ϩ preconditioning. Cardioprotection induced by ischemic preconditioning and Ca 2ϩ preconditioning is mediated via Ca 2ϩ and reduction of cellular Ca 2ϩ influx reduces PKC activation and subsequent protection against I/R-injury. 1 Sevoflurane reduces myocardial Ca 2ϩ availability, but paradoxically increases sarcoplasmic reticulum (SR) Ca 2ϩ content. 2 Changes in cellular SR Ca 2ϩ load are associated with activation of survival and/or death signaling pathways, 3 and therefore provide a potential mechanism for cardioprotective signaling. Sevoflurane reduces Ca 2ϩ influx via the L-type Ca 2ϩ channels, 4 and therefore another Ca 2ϩ -loading mechanism may be involved. One of the key regulation proteins of myocardial Ca 2ϩ loading is t...